Global Cancer Technology: GCT-007 for Glioblastoma
Context brief on GBM therapeutics: evidence questions, trial reality, and translation risk.
This page collects GigHz portfolio items tagged Biotech. Expect concise briefs on what the project is, why it matters, and the constraints that decide outcomes.
Back to Our WorkContext brief on GBM therapeutics: evidence questions, trial reality, and translation risk.
Context brief on de-extinction/platform biotech: constraints, ethics, and translation risk.